Public Profile

Yangtze River Pharma

Yangtze River Pharma, a prominent player in the pharmaceutical industry, is headquartered in China (CN) and operates extensively across various regions. Founded in the early 2000s, the company has established itself as a leader in the development and manufacturing of innovative pharmaceutical products, particularly in the fields of oncology and cardiovascular health. With a commitment to quality and research-driven solutions, Yangtze River Pharma offers a diverse portfolio of prescription medications and generics that stand out for their efficacy and safety. The company has achieved significant milestones, including numerous regulatory approvals and partnerships that enhance its market position. Recognised for its contributions to healthcare, Yangtze River Pharma continues to advance its mission of improving patient outcomes through cutting-edge therapies and a robust pipeline of new products.

DitchCarbon Score

How does Yangtze River Pharma's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

0

Industry Average

Mean score of companies in the Chemicals industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

6

Industry Benchmark

Yangtze River Pharma's score of 0 is lower than 70% of the industry. This can give you a sense of how well the company is doing compared to its peers.

30%

Yangtze River Pharma's reported carbon emissions

Yangtze River Pharma, headquartered in China (CN), currently does not have publicly available carbon emissions data or specific reduction targets. Without emissions figures, it is challenging to assess their carbon footprint or climate commitments. However, the pharmaceutical industry is increasingly focusing on sustainability and reducing greenhouse gas emissions. Companies in this sector are often encouraged to adopt science-based targets and engage in initiatives aimed at minimising their environmental impact. Yangtze River Pharma may be participating in such industry trends, but specific commitments or achievements have not been disclosed.

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. Yangtze River Pharma's primary industry is Chemicals nec, which is medium in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. Yangtze River Pharma is headquartered in CN, which we do not have grid emissions data for.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

Yangtze River Pharma is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
Carbon Disclosure Project
The Climate Pledge
UN Global Compact

Other Organizations in Chemicals

JSR Micro

US
Chemicals
Updated 10 days ago

INEOS

DE
Chemicals
Updated 10 days ago

LAMBERTI

IT
Chemicals
Updated 10 days ago

MALFANTI SA

CL
Chemicals
Updated 10 days ago

Desbro Kenya Ltd.

KE
Chemicals
Updated 3 days ago

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers